JP2009534404A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534404A5
JP2009534404A5 JP2009506740A JP2009506740A JP2009534404A5 JP 2009534404 A5 JP2009534404 A5 JP 2009534404A5 JP 2009506740 A JP2009506740 A JP 2009506740A JP 2009506740 A JP2009506740 A JP 2009506740A JP 2009534404 A5 JP2009534404 A5 JP 2009534404A5
Authority
JP
Japan
Prior art keywords
alkyl
och
conhch
pyridyl
propenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009506740A
Other languages
English (en)
Japanese (ja)
Other versions
JP5480619B2 (ja
JP2009534404A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/066864 external-priority patent/WO2007124318A1/en
Publication of JP2009534404A publication Critical patent/JP2009534404A/ja
Publication of JP2009534404A5 publication Critical patent/JP2009534404A5/ja
Application granted granted Critical
Publication of JP5480619B2 publication Critical patent/JP5480619B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009506740A 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤 Expired - Fee Related JP5480619B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US79369406P 2006-04-20 2006-04-20
US60/793,694 2006-04-20
US87117106P 2006-12-21 2006-12-21
US60/871,171 2006-12-21
PCT/US2007/066864 WO2007124318A1 (en) 2006-04-20 2007-04-18 Inhibitors of c-fms kinase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013228539A Division JP5932754B2 (ja) 2006-04-20 2013-11-01 c−fmsキナーゼの阻害剤

Publications (3)

Publication Number Publication Date
JP2009534404A JP2009534404A (ja) 2009-09-24
JP2009534404A5 true JP2009534404A5 (enExample) 2010-05-13
JP5480619B2 JP5480619B2 (ja) 2014-04-23

Family

ID=38457966

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009506740A Expired - Fee Related JP5480619B2 (ja) 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤
JP2013228539A Expired - Fee Related JP5932754B2 (ja) 2006-04-20 2013-11-01 c−fmsキナーゼの阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013228539A Expired - Fee Related JP5932754B2 (ja) 2006-04-20 2013-11-01 c−fmsキナーゼの阻害剤

Country Status (14)

Country Link
US (3) US8674100B2 (enExample)
EP (2) EP2687516A1 (enExample)
JP (2) JP5480619B2 (enExample)
KR (1) KR101462393B1 (enExample)
AR (1) AR060609A1 (enExample)
AU (1) AU2007240439B2 (enExample)
CA (1) CA2649919C (enExample)
ES (1) ES2581600T3 (enExample)
MX (1) MX2008013532A (enExample)
NZ (1) NZ572201A (enExample)
PE (1) PE20080076A1 (enExample)
TW (1) TW200808736A (enExample)
UY (1) UY30298A1 (enExample)
WO (1) WO2007124318A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006002421A2 (en) 2004-06-24 2006-01-05 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
US20060281788A1 (en) * 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
AU2006332726B2 (en) 2005-12-28 2012-12-13 Vertex Pharmaceuticals Incorporated. Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
KR101367645B1 (ko) 2006-04-20 2014-02-27 얀센 파마슈티카 엔.브이. C-fms 키나제의 저해제로서의 복소환식 화합물
KR101367646B1 (ko) 2006-04-20 2014-02-27 얀센 파마슈티카 엔.브이. C-fms 키나제의 저해제
US8697716B2 (en) 2006-04-20 2014-04-15 Janssen Pharmaceutica Nv Method of inhibiting C-KIT kinase
AU2007240439B2 (en) * 2006-04-20 2012-10-11 Janssen Pharmaceutica N.V. Inhibitors of c-fms kinase
JO3240B1 (ar) * 2007-10-17 2018-03-08 Janssen Pharmaceutica Nv c-fms مثبطات كيناز
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
AU2010226400B2 (en) * 2009-03-20 2016-07-14 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
CN101624376B (zh) * 2009-08-19 2011-09-14 沈阳中海药业有限公司 取代酰肼类化合物及其应用
NZ597620A (en) * 2009-08-20 2013-08-30 Cipla Ltd A process for the synthesis of naratriptan
WO2011149874A2 (en) * 2010-05-26 2011-12-01 Schering Corporation N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
CA2865519C (en) 2012-02-27 2018-01-02 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl0-5-hydroxyphenyl-1]-1,4-dihydro-4-oxoquinolone-3-carboxamide for treating cystic fibrosis
JOP20180012A1 (ar) 2012-08-07 2019-01-30 Janssen Pharmaceutica Nv عملية السلفنة باستخدام نونافلوروبوتانيسولفونيل فلوريد
US9303046B2 (en) 2012-08-07 2016-04-05 Janssen Pharmaceutica Nv Process for the preparation of heterocyclic ester derivatives
KR101676208B1 (ko) * 2012-09-17 2016-11-14 에프. 호프만-라 로슈 아게 트라이아졸 카복스아미드 유도체
JP6318467B2 (ja) * 2013-04-18 2018-05-09 Jsr株式会社 液晶配向剤、液晶配向膜、液晶表示素子、位相差フィルム、位相差フィルムの製造方法及び重合体
US10959987B2 (en) 2019-04-15 2021-03-30 King Abdulaziz University Imidazole-based compounds as hepatitis C virus inhibitors
WO2021144360A1 (en) 2020-01-17 2021-07-22 F. Hoffmann-La Roche Ag Small molecule csf-1r inhibitors in therapeutic and cosmetic uses

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE138365T1 (de) * 1991-11-27 1996-06-15 Du Pont Herbizide acylierte amino-(phenyl-oder-pyridinyl- oder thienyl-)phenyl derivate
JPH10507185A (ja) 1994-10-14 1998-07-14 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 2−(イミダゾール−4−イル)カルバペネム誘導体、その中間体および抗菌剤としての使用
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
WO1997020822A1 (en) 1995-12-01 1997-06-12 Novartis Ag Quinazolin-2,4-diazirines as npy receptor antagonist
US6100254A (en) 1997-10-10 2000-08-08 Board Of Regents, The University Of Texas System Inhibitors of protein tyrosine kinases
GB9824579D0 (en) 1998-11-10 1999-01-06 Novartis Ag Organic compounds
EP1140938B1 (en) 1999-01-11 2003-08-27 Princeton University High affinity inhibitors for target validation and uses thereof
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
CA2396693A1 (en) 1999-12-28 2001-07-05 Stephen T. Wrobleski Cytokine, especially tnf-alpha, inhibitors
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
EP1631560A2 (en) 2003-04-25 2006-03-08 3-Dimensional Pharmaceuticals, Inc. C-fms kinase inhibitors
US7427683B2 (en) * 2003-04-25 2008-09-23 Ortho-Mcneil Pharmaceutical, Inc. c-fms kinase inhibitors
US7790724B2 (en) * 2003-04-25 2010-09-07 Janssen Pharmaceutica N.V. c-fms kinase inhibitors
US20050113566A1 (en) * 2003-04-25 2005-05-26 Player Mark R. Inhibitors of C-FMS kinase
US7662837B2 (en) * 2004-10-22 2010-02-16 Janssen Pharmaceutica N.V. Inhibitors of c-fms kinase
US7645755B2 (en) * 2004-10-22 2010-01-12 Janssen Pharmaceutical N.V. Inhibitors of c-fms kinase
JP5008569B2 (ja) * 2004-10-22 2012-08-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ C−fmsキナーゼのインヒビターとしての芳香族アミド
CN101421280A (zh) * 2006-04-12 2009-04-29 惠氏公司 作为5-羟色胺-6配体的经取代二氢[1,4]噁嗪并[2.3.4-hi]吲唑衍生物
KR101367645B1 (ko) * 2006-04-20 2014-02-27 얀센 파마슈티카 엔.브이. C-fms 키나제의 저해제로서의 복소환식 화합물
AU2007240439B2 (en) * 2006-04-20 2012-10-11 Janssen Pharmaceutica N.V. Inhibitors of c-fms kinase
KR101367646B1 (ko) * 2006-04-20 2014-02-27 얀센 파마슈티카 엔.브이. C-fms 키나제의 저해제
FR2966596B1 (fr) * 2010-10-26 2012-12-07 Commissariat Energie Atomique Dispositif de detection d'un rayonnement electromagnetique.

Similar Documents

Publication Publication Date Title
JP2009534404A5 (enExample)
JP2009534407A5 (enExample)
JP2008510828A5 (enExample)
JP6466348B2 (ja) スルファモイル−アリールアミドおよびb型肝炎を処置するための医薬品としてのその使用
JP2002524463A5 (enExample)
JP2011507878A5 (enExample)
JP2012524111A5 (enExample)
JP2012510523A5 (enExample)
JP2009534406A5 (enExample)
JP2013532726A5 (enExample)
JP2011520815A5 (enExample)
JP2009534405A5 (enExample)
JP2007501859A5 (enExample)
JP2007518738A5 (enExample)
JP2008505120A5 (enExample)
JP2012530713A5 (enExample)
JPWO2020123827A5 (enExample)
JP2009539828A5 (enExample)
JP2007269797A5 (enExample)
RU2003133448A (ru) 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс- хемокинового рецептора
JP2006515858A5 (enExample)
JP2010539110A5 (enExample)
JP2005511608A5 (enExample)
JP2013510825A5 (enExample)
JP2010514681A5 (enExample)